Food Study of Rabeprazole Sodium Delayed-Release Tablets 20 mg to Aciphex® Tablets 20 mg
Status:
Completed
Trial end date:
2003-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the bioequivalence of Mylan's rabeprazole
sodium delayed-release 20 mg tablets relative to Eisai's Aciphex® delayed-release 20 mg
tablets following a single, oral 20 mg (1 x 20 mg) dose administration under fed conditions.